We investigated the relationship between protein and tryptophan intake and the adverse-effect-level of di(2-ethylhexyl)phthalate (DEHP). Growth retardation of young rats due to DEHP was strengthened by increasing protein level. The addition of tryptophan to the diet caused extreme increases in the nicotinamide formation, but no growth retardation was observed.
DEHP is a ubiquitous environmental contaminant due to its extensive use as a plasticizer. 1) Since phthalate plasticizers are not chemically bound to polyvinylchloride plastics, they can leach, migrate, or evaporate into indoor air and atmosphere, foodstuffs, and other materials. These esters have been detected in animals and humans. [2] [3] [4] We have reported that the administration of phthalic acid esters such as dibutylphtahlate 5, 6) and DEHP [7] [8] [9] [10] [11] [12] disturbed the metabolism of de novo NAD biosynthesis. Concretely, the administration of phthalic acid esters increased the formation of QA (a key intermediate of the de novo NAD biosynthesis) and its metabolites. 7) For example, the conversion ratio of Trp to Nam was abnormally increased up to 30% by feeding of a diet containing 3% DEHP, while the conversion ratio of group on a non-DEHP diet was about 2%. 7) Handler et al. 13) and Shibata and Tanaka 14) have reported that the intake of an excess of Nam caused retarded growth in young rats. We have proposed that part of growth retardation in young rats due to phthalic acid esters is attributable to excess Nam formation. Objective of the present study was to test this hypothesis. Here we report that our hypothesis was clearly disconfirmed.
NAD
þ and NADP þ were purchased from Sigma Chemical Company (St. Louis, MO). Vitamin-free milk casein, sucrose, L-methionine, Nam, and QA were purchased from Wako Pure Chemical Industries (Osaka, Japan). KA, XA, and MNA chloride were purchased from Tokyo Chemical Industry (Tokyo). 2-Py and 4-Py were synthesized by the methods of Pullman and Colowick 15) and Shibata et al. 16) respectively. Corn oil was purchased from Ajinomoto (Tokyo). Mineral and vitamin mixtures and gelatinized cornstarch were obtained from Oriental Yeast (Tokyo). All the other chemicals used were of the highest purity available from commercial sources.
The care and treatment of the experimental animals conformed to The University of Shiga Prefecture guidelines for the ethical treatment of laboratory animals. Male rats of the Wistar strain (3 weeks old with a body weight of about 40 g) were obtained from CLEA Japan (Tokyo). They were immediately placed in individual metabolic cages (CT-10; Clea Japan). In experiment 1, the rats were divided into five groups and fed ad libitum for 21 d on 40% casein diets 17) containing a niacin-free AIN-93 vitamin mixture with 0, 0.1, 0.5, 1.0, and 2.0% DEHP. In experiment 2, the rats were divided six groups and fed ad libitum for 21 d on niacin-free 20% casein diets, 7) with 0, 0.1, and 0.5% Trp with and without 0.1% DEHP. The room temperature was maintained at about 20 C and about 60% humidity, and a 12-h light/12-h dark cycle was maintained. Body weight and food intake were measured daily at about 10:00 AM. In experiment 2, urine samples (24-h; 10:00 AM-10:00 AM) on the last day were collected in amber bottles containing 1 ml of 1 M HCl, stored at À20 C until needed. The rats were killed by decapitation. liver of each animal was removed, and a portion (approximately 0.2 g) was immediately treated as described in the literature. 18, 19) The contents of NAD (NAD þ þ NADH) and NADP (NADP þ þ NADPH) were measured by the colorimetric methods of Shibata and Murata 18) and Shibata and Tanaka 19) respectively. The urinary contents of Nam and of the catabolic metabolites MNA, 2-Py, and 4-Py were measured. The contents of Nam, 2-Py, and 4-Py in the urine were simultaneously measured by the HPLC method of Shibata et al., 16) while the content of MNA in the urine was measured by the HPLC method of Shibata.
20) The contents of KA, 21) XA, 22) 3-HA, 22) AnA, 23) and QA 24) in the urine were measured by the HPLC method.
We have reported that growth retardation of young rats due to DEHP appeared at a level of 1.0% on a 20% casein diet. 7) Body weight gain on day 21 was 68:2 AE 2:5 g in the 40% casein diet group. It was 62:4 AE 2:7 g on a diet with 0.1% DEHP group, with no growth retardation, while growth retardation was observed at 0.5% on the 40% casein diet. Body weight gains at day 21 were 21:2 AE 3:9 g, 11:8 AE 3:5 g, and À9:4 AE 2:1 g on the diets with 0.5%, 1.0%, and 2.0% respectively.
The addition of free Trp to the DEHP diet did not affect body weight gain or food intake, as shown in Fig. 1 . Liver weight was higher on each DEHP diet than on respective non-DEHP diet, as shown in Table 1 . Liver weight was not affected by adding free Trp. NAD concentrations in the livers showed a tendency to increase with Trp intake. DEHP administration caused further increases in NAD concentration.
The metabolites of Trp to Nam were increased dosedependent manner due to the addition of free Trp, as shown in Table 2 . DEHP intake caused QA to increase extremely, as well as metabolites such as Nam, MNA, 2-Py, and 4-Py. Therefore, the conversion ratio of Trp to Male rats of the Wistar strain (6 weeks old) were placed in individual metabolic cages. They were divided into six groups and then fed freely a 20% casein diet supplemented with 0% Trp (A and D), 0.1% Trp (B and E), or 0.5% Trp (C and F) with or without 0.1% DEHP for 21 d. , 0% DEHP diet; , 0.1% DEHP diet. Each point is the mean AE SEM (n ¼ 5). Nam was higher in each of DEHP groups than in the respective non-DEHP groups. Shibata and Iwai have reported in 1980 that phthalic acid, an analog of QA, is a strong competitive inhibitor of quinolinate phosphoribosyltransferase (QPRT). 25) Hence, we investigated to determine whether the administration of phthalic acid esters, widely used as plasticizers, would cause adverse effects on rats when they were fed a niacin-deficient diet. Shibata et al. found in 1982 that growth promoting activity due to appropriate phthalic acid esters occurred when rats were fed a niacin-free, Trp-limiting diet. 26) We were surprised at that phenomenon, and so we started to sort out the contradiction. We found and have reported that mono(ethylhexyl)phthalate (MEHP), a metabolite of DEHP, inhibits the enzyme activity of ACMSD, and increases the formation of QA, causing it to increase further metabolites such as Nam. [7] [8] [9] [10] [11] [12] Phthalic acid does not accumulate in the liver, so the reaction of QPRT might not be inhibited.
2-way ANOVA p-values -----------------------------------------------------
Phthalic acid esters are known to have adverse effects on mammals. 4) We have reported that the addition of a large amount of DEHP caused growth restriction. 7) Under such conditions, the conversion ratio of Trp to Nam increased extremely up to 30%, which mean that Nam formation in the body was about 35 mg/kg body weight of rat. 7) Nam administration of 40 mg/kg of body weight of rat caused significant growth retardation. 14) Hence, we present the hypothesis that part of the growth retardation induced by phthalic acid esters is due to the production of excess Nam. In the present experiment, we investigated whether the administration of a high-protein diet that contained high Trp to rats could cause a strengthening of growth retardation by DEHP. Growth retardation was observed at a level of 0.5% DEHP in the 40% casein diets, while we have reported that in the 20% casein diets, the retardation appeared at a level of 1.0% DEHP. 7) We found that feeding the high protein diet strengthened growth retardation due to DEHP. We investigated to determine whether the strengthened growth retardation due to feeding the high protein diet is attributed to high Trp intake. The addition of Trp only to the 20% casein diet containing 0.1% DEHP did not cause apparent growth retardation. A concentration of 0.1% DEHP was chosen because we anticipated that growth retardation would be strengthened by the addition of Trp, but no retardation of the body weight gain or food intake in young rats was observed (Fig. 1) , although the conversion ratio was over 20% in the group consuming a 0.1% free Trp added diet containing 0.1% DEHP (Table 2) , which indicates 60 mg of Nam formation per kilogram of body weight. Furthermore, -------------------------------------------------------------------------------------------------------------- in the group consuming a 0.5% free Trp added diet containing 0.1% DEHP, Nam formation in the body was about 150 mg per kilogram body weight. Nevertheless, the body weight gain and food intake were almost the same as in the group on the 20% casein diet (control). These results indicate that our hypothesis that part of DEHP-growth retardation is due to an excess of Nam, is not plausible. In addition, the present data indicate that the growth retardation level in young rats exogenously taken excess Nam is lower than in rats endogenously formed excess Nam. This phenomenon implies that the peak concentration of Nam is the most important point in the toxicity of Nam, that is, as to whether Nam causes growth retardation. Even if the endogenous formation of Nam in 1 d are almost the same as the administered amount of exogenous Nam in 1 d, the peak Nam concentration in the body should not be much lower in endogenous Nam than in exogenous Nam, because endogenous Nam is continuously metabolized, or synthesized and catabolized, while the exogenous Nam causes an abrupt increase in the concentration of Nam in the body.
